Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Placebo Evaluate”

12,371 trials

Showing 20 of 12,371 results

Early research (Phase 1)Study completedNCT05496738
What this trial is testing

A Preliminary Study to Evaluate PF-07264660 in Healthy Participants

Who this might be right for
Healthy
Pfizer 59
Large-scale testing (Phase 3)Study completedNCT00210548
What this trial is testing

Evaluate the Effectiveness and Safety of 3 Doses of Paliperidone Palmitate in Treating Subjects With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 366
Not applicableStudy completedNCT02591355
What this trial is testing

Evaluate the Clinical Effectiveness of RegenKit Platelet-rich Plasma (PRP) in Androgenetic Alopecia Treatment

Who this might be right for
Androgenetic Alopecia
Regen Lab SA 80
Large-scale testing (Phase 3)Ended earlyNCT00338585
What this trial is testing

Study of Alfimeprase's Ability to Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery

Who this might be right for
Arterial Occlusive Diseases
ARCA Biopharma, Inc. 300
Testing effectiveness (Phase 2)Looking for participantsNCT06891417
What this trial is testing

Phase 1/2 Study of Chlamydia Trachomatis mRNA Vaccine in Adults Aged 18 to 29 Years

Who this might be right for
Chlamydia Trachomatis Immunization
Sanofi 1,560
Testing effectiveness (Phase 2)Study completedNCT01513291
What this trial is testing

The Safety and Efficacy of MK-6096 for Migraine Prophylaxis in Participants With Episodic Migraine (MK-6096-020)

Who this might be right for
MigraineHeadache
Merck Sharp & Dohme LLC 237
Early research (Phase 1)Study completedNCT02091310
What this trial is testing

Phase I Study to Evaluate the Effect of GFT505 on QT/QTc Interval in Healthy Volunteers

Who this might be right for
Healthy Volunteers
Genfit 200
Early research (Phase 1)Study completedNCT00886613
What this trial is testing

Evaluate Immunity to Varicella Zoster Virus After Immunization With V212 Vaccine or Zostavax (V212-003)

Who this might be right for
Herpes Zoster
Merck Sharp & Dohme LLC 120
Testing effectiveness (Phase 2)Study completedNCT01030679
What this trial is testing

Evaluate the Glycemic Control of CKD-501 in Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Chong Kun Dang Pharmaceutical 214
Testing effectiveness (Phase 2)WithdrawnNCT06099418
What this trial is testing

Efficacy and Safety of VB10.16 Alone or in Combination With Atezolizumab in Patients With Advanced Cervical Cancer.

Who this might be right for
HPV-Related Cervical CarcinomaHPV-Related MalignancyCervical Cancer
Nykode Therapeutics ASA
Large-scale testing (Phase 3)Study completedNCT05039190
What this trial is testing

Evaluate the Efficacy and Safety of HBM9161(HL161)Subcutaneous Injection in Patients With Generalized MG Patients

Who this might be right for
Myasthenia Gravis
Harbour BioMed (Guangzhou) Co. Ltd. 132
Early research (Phase 1)Study completedNCT06128382
What this trial is testing

First-in-human Study to Evaluate the Safety and Immunogenicity of Three Dose Levels of the OVX033 Coronavirus Vaccine Candidate in Healthy Volunteers

Who this might be right for
Coronavirus
Osivax 48
Testing effectiveness (Phase 2)WithdrawnNCT02563782
What this trial is testing

Study to Evaluate Sub-retinal Transplantation of Retinal Pigmented Epithelial Cells in Patients With Dry AMD

Who this might be right for
Age-Related Macular Degeneration
Astellas Institute for Regenerative Medicine
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06926582
What this trial is testing

Evaluate Efficacy and Safety of HS-10374 for Mild-to-moderate Plaque Psoriasis

Who this might be right for
Psoriasis
Hansoh BioMedical R&D Company 305
Large-scale testing (Phase 3)Study completedNCT01807923
What this trial is testing

Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation

Who this might be right for
Cystic Fibrosis, Homozygous for the F508del CFTR Mutation
Vertex Pharmaceuticals Incorporated 559
Testing effectiveness (Phase 2)Ended earlyNCT02010203
What this trial is testing

HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT

Who this might be right for
Bladder Cancer
Heat Biologics 104
Testing effectiveness (Phase 2)Looking for participantsNCT05778188
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia

Who this might be right for
Hypoxic-Ischemic Encephalopathy
ReAlta Life Sciences, Inc. 70
Large-scale testing (Phase 3)Active Not RecruitingNCT06921486
What this trial is testing

The Efficacy and Safety of Efsubaglutide Alfa Injection in Overweight and Obese Subjects (ENLIGHT)

Who this might be right for
Obesity and Overweight
Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. 1,003
Testing effectiveness (Phase 2)Study completedNCT02918318
What this trial is testing

Evaluate the Efficacy, Safety and Tolerability of Fixed Doses of Intranasal Esketamine in Japanese Participants With Treatment Resistant Depression

Who this might be right for
Depression
Janssen Pharmaceutical K.K. 202
Testing effectiveness (Phase 2)Ended earlyNCT00874796
What this trial is testing

Efficacy and Safety Study of GS-9450 Treatment for 6 Months in Patients With Chronic Hepatitis C Virus Infection

Who this might be right for
HCV Infection
Gilead Sciences 307
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation